Two doctors, Geoffrey Guy and Brian Whittle, founded GW Pharmaceuticals and the same year obtained a licence from the Home Office and the medicines regulator to cultivate, possess and supply cannabis for scientific research. Its mouth spray Sativex, a cannabis extract, became the first natural cannabis derivative to gain market approval in any country, and was approved in the United Kingdom in 2010 for multiple sclerosis.[1]
Listed for context. No score change is recorded for United Kingdom here.
References
Checked. The date and the event were compared with a source that was read.